These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10379189)

  • 1. [Octreotide and a serotonin-secreting glomus tumor].
    García Galán F; Hernández Gudino S; Estrada Fernández J; García-Baquero A
    Rev Esp Anestesiol Reanim; 1999 May; 46(5):219-22. PubMed ID: 10379189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium in the management of catecholamine-secreting glomus tumours with intracranial extension.
    Goutcher CM; Cossar DF; Ratnasabapathy U; Burke AM
    Can J Anaesth; 2006 Mar; 53(3):316-21. PubMed ID: 16527799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the carcinoid syndrome with somatostatin, salmon calcitonin, or octreotide.
    Antonelli A; Gambuzza C; Bertoni F; Baschieri L
    Clin Ther; 1992; 14(2):178-84. PubMed ID: 1377097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative octreotide for refractory carcinoid-induced bronchospasm.
    Quinlivan JK; Roberts WA
    Anesth Analg; 1994 Feb; 78(2):400-2. PubMed ID: 8311295
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sudden onset of bronchospasm and persistent hypotension during spinal anesthesia in a patient on long-term psychotropic therapy].
    Sawada N; Higashi K; Yanagi F; Nishi M; Akasaka T; Kudoh J
    Masui; 1997 Sep; 46(9):1225-9. PubMed ID: 9311216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of octreotide in the treatment of digestive endocrine tumors. A French multicenter study].
    Blanchin M; James-Deidier A; Chaumet-Riffaud PD; Chayvialle JA
    Presse Med; 1992 Apr; 21(15):697-702. PubMed ID: 1376476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure.
    Alam M; Smith G; Bleasdale-Barr K; Pavitt DV; Mathias CJ
    J Hypertens; 1995 Dec; 13(12 Pt 2):1664-9. PubMed ID: 8903629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A prolonged-action somatostatin analog and carcinoid syndrome].
    Chayvialle JA
    Bull Acad Natl Med; 1989 May; 173(5):643-50; discussion 650-1. PubMed ID: 2478266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of octreotide infusion, surgery and estrogen on suppression of height increase and 20K growth hormone ratio in a girl with gigantism due to a growth hormone-secreting macroadenoma.
    Minagawa M; Yasuda T; Someya T; Kohno Y; Saeki N; Hashimoto Y
    Horm Res; 2000; 53(3):157-60. PubMed ID: 11044798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe orthostatic hypotension with the somatostatin analogue octreotide.
    Woo J; Or KH; Teoh R; Nicholls MG
    Aust N Z J Med; 1990 Dec; 20(6):822-3. PubMed ID: 2291734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of heliox for intraoperative bronchospasm: a case report.
    Linck SL
    AANA J; 2007 Jun; 75(3):189-92. PubMed ID: 17591299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uneventful spinal anesthesia for a patient with carcinoid syndrome managed with long-acting octreotide.
    Orbach-Zinger S; Lombroso R; Eidelman LA
    Can J Anaesth; 2002; 49(7):678-81. PubMed ID: 12193484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide for treatment of intraoperative hypotension due to an unexpected neuroblastoma in an adult.
    Jaffe RS; Ankunding J; Goodnight J
    Anesthesiology; 1994 Nov; 81(5):1294-6. PubMed ID: 7978489
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of pharmacological effect of subcutaneous octreotide in an insulin-dependent diabetic patient: reversal after mixing with aprotinin.
    Lunetta M; Di Mauro M; Le Moli R
    J Endocrinol Invest; 1997 Jun; 20(6):331-4. PubMed ID: 9294779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous octreotide treatment for acute experimental pancreatitis.
    Greenberg R; Haddad R; Kashtan H; Brazowski E; Graff E; Skornick Y; Kaplan O
    Digestion; 1999; 60(2):125-31. PubMed ID: 10095153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glomus jugulare tumor: perioperative management].
    Ferrando A; Fraile JR; Bermejo L; de Miguel A; Aristegui M; Hervías M; Quirós P
    Rev Esp Anestesiol Reanim; 1996 Dec; 43(10):371-4. PubMed ID: 9019790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
    Condron ME; Pommier SJ; Pommier RF
    Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
    Fukuhara N; Horiguchi K; Nishioka H; Suzuki H; Takeshita A; Takeuchi Y; Inoshita N; Yamada S
    Endocr J; 2015; 62(1):21-7. PubMed ID: 25273395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.